Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
bofutrelvir (FB2001) / Frontier Biotech
NCT05675072: Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19	Recruiting	2/3	1336	RoW	FB2001, FB2001 for Inhalation, FB2001 placebo, placebo	Frontier Biotechnologies Inc.	Mild to Moderate COVID-19	09/23	12/23
NCT05445934: Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)	Recruiting	2/3	1188	RoW	FB2001, DC402234, FB2001 placebo	Frontier Biotechnologies Inc.	COVID-19	11/23	12/23
NCT05415241: Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts	Not yet recruiting	1/2	60	NA	FB2001	Ruijin Hospital, Frontier Biotechnologies Inc., Shanghai Center for Disease Control and Prevention	Close Contact Transmission	08/22	12/22